JP Patent

JP5394423B2 — プロテアソーム酵素阻害のための化合物

Assigned to Onyx Therapeutics Inc · Expires 2014-01-22 · 12y expired

What this patent protects

Patent listed against Kyprolis.

Drugs covered by this patent

Kyprolis (carfilzomib) · Amgen

Patent Metadata

Patent number: JP5394423B2
Jurisdiction: JP
Classification: —
Expires: 2014-01-22
Drug substance claim: No
Drug product claim: No
Assignee: Onyx Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.